Physician profile
Julia Barroca
NPI 1952007320
$328.35
in general payments reported to CMS, 2019-2025
10 companies · $16.72 in 2025
The $16.72 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $246 · 2024: $65.30 · 2025: $16.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $328.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $56.12 | 2023 | Keytruda, Lynparza, Welireg |
| Janssen Biotech, INC. | $53.46 | 2023 | Tecvayli, Darzalex |
| Incyte Corporation | $43.94 | 2023 | Monjuvi, Pemazyre, Jakafi |
| Glaxosmithkline, LLC. | $42.09 | 2023-2024 | Jemperli, Zejula |
| Seagen INC. | $27.91 | 2023 | Padcev |
| Abbvie INC. | $23.50 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.83 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.45 | 2024 | Alunbrig |
| Coherus Oncology, INC. | $21.33 | 2023 | |
| Puma Biotechnology, INC. | $16.72 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Barroca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.